Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAMPART: IM Midazolam vs IV Lorazepam for Status Epilepticus
NCT00809146Phase 3Completed
- Start
- Jun 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam in status epilepticus (SE). Started Jun 2009; status: completed.
02
Drugs
midazolam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT00809146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809146.